No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Iterum Therapeutics Analyst Ratings
Express News | Iterum Therapeutics PLC : H.c. Wainwright Assumes Coverage With Buy Rating; Price Target $9
Iterum Therapeutics (ITRM.US) will release its Earnings Reports before the market opens on May 13.
$Iterum Therapeutics(ITRM.US)$ will release its Earnings Reports before the market opens on May 13, and investors are encouraged to pay attention. Futubull reminder: 1. There are no strict regulations for the fiscal year divisions of Hong Kong and U.S. listed companies; it is entirely decided by the companies themselves, so each Earnings Reports period can serve as the fiscal year-end for the company, rather than conforming to the natural year as the fiscal year. 2. Generally, the company will hold an Earnings Reports meeting on or around the date of the above Earnings Reports release, during which the company's management will discuss and explain the latest quarterly Earnings Reports data and operational status, and interact with investors.
Iterum Therapeutics to Report First Quarter 2025 Financial Results on May 13, 2025
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Express News | Iterum Therapeutics Announces $5 Million Registered Direct Offering of Ordinary Shares
